Sleep architecture research
Slow-wave sleep declines significantly during perimenopause. GHRH-analog research has examined slow-wave sleep parameters in mixed-sex cohorts.
Hormone
CJC-1295
Pulsatile GH release
A modified GHRH peptide investigated for sustained growth-hormone secretion patterns.
$44.99per vial · research use
Quantity
Up to 50%
- GH pulse research
- Sleep architecture studies
- Body composition models
For research use only. Not for human consumption.
Women's research notes
What researchers study CJC-1295 for in women
CJC-1295 pre-clinical and early clinical research is referenced in studies of sleep architecture, body composition, and GH-axis decline that disproportionately affects women in mid-life.
Body composition studies
Pre-clinical research has measured lean mass and adipose changes following GHRH-analog administration in female models.
GH pulsatility
Research focuses on restoring physiologic GH pulse patterns, which decline more steeply in women after menopause.
Selected literature
- Teichman SL, et al. JCEM 2006 — CJC-1295 pharmacokinetics
- Ionescu M, Frohman LA. JCEM 2006 — GHRH analogs and pulsatile GH
Information below summarizes published pre-clinical and clinical research. It is provided for educational purposes for qualified researchers and is not medical advice, a treatment recommendation, or a claim of efficacy. Products are sold for research use only.
